Business Wire

DE-CIX Launches ‘Project Reach’ with Bandwidth Infrastructure Partner euNetworks

Jaa

DE-CIX, the world’s leading Internet Exchange operator, today announced the launch of ‘Project Reach’, together with its launching partner euNetworks. Project Reach focuses on DE-CIX’s desire to extend its reach into more data centres, therefore expanding the locations where customers can connect to and access the DE-CIX peering platform. DE-CIX partners with carriers, leveraging their transport networks and points of presence (PoPs) for additional access. In addition to existing DE-CIX enabled sites, where DE-CIX maintains its own hardware, these new access sites are added with partners – such as euNetworks – who maintain and manage the hardware.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180711005276/en/

Brady Rafuse (Photo: Business Wire)

Brady Rafuse (Photo: Business Wire)

“We want to make it easy for peers located in any data centre to connect to our DE-CIX Service World,” said Dr. Thomas King, Chief Innovation Office at DE-CIX. “euNetworks has an impressive network footprint across Germany and Europe. Their focus on connecting to all the key data centres across the region with fibre, combined with their service performance and delivery capability, makes euNetworks an ideal partner as we launch this project. We’re excited to be able to offer our customers an extended ‘one-stop-shop’ solution.”

euNetworks owns and operates deep, fibre based networks in 14 cities across Europe, with 7 of these in Germany. Along with a Pan German backbone, euNetworks’ long haul network spans 49 cities in 15 countries, offering both scalability and diversity across its footprint. euNetworks directly connects to over 350 data centres in its operating markets, with these sites being key to high bandwidth consuming companies.

“We’re excited to be supporting DE-CIX as they seek to extend their geographical reach to customers,” said Brady Rafuse, Chief Executive Officer of euNetworks. “We have a great working relationship with the DE-CIX team and this partnership extends that further, with the euNetworks Customer Ordering Portal and Ethernet services supporting a smooth and rapid service delivery experience to the DE-CIX community.”

euNetworks Carrier Ethernet service to support DE-CIX Project Reach:

  • Plug and play with portal ordering process
  • Layer 2 architecture VPLS/MPLS
  • MEF certified carrier class Ethernet
  • Segmentation of traffic through customer VLANS
  • Backbone protected
  • Customer ports at euNetworks’ connected data centres
  • 10G Ethernet NNI to DE-CIX and dedicated 10G ports

About euNetworks

euNetworks is a bandwidth infrastructure company, owning and operating 14 fibre based metropolitan networks connected with a high capacity intercity backbone covering 49 cities in 15 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 350 today. euNetworks is also a leading cloud connectivity provider, directly connecting 14 cloud platforms with access to a further 7. The company offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs.

For further information visit www.eunetworks.com.

About DE-CIX

DE-CIX provides premium interconnection services and runs a range of carrier and data center-neutral IXs globally. Founded in 1995, DE-CIX serves 1300+ carriers, ISPs and content networks from 100+ countries, including all leading international players in various metro markets in Europe, the Middle East, India and North America.

With 6.4+ Terabits per second of peak traffic, DE-CIX Frankfurt is the world’s leading Internet Exchange. For more information, please visit www.de-cix.net.

Contact information

euNetworks contact:
Hannah Britt
Senior Director, Marketing & IR
hannah.britt@eunetworks.com
+44 20 7952 1338
+44 7717 896 446
or
DE-CIX media contact:
Carsten Titt
Senior Manager Global Public Relations
+49 (0)69 1730902 130
carsten.titt@de-cix.net
www.de-cix.net

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41Tiedote

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42Tiedote

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00Tiedote

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 10:58Tiedote

Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme